Cleared Traditional

K811562 - TOXOPLASMOSIS TEST KIT

K811562 is an FDA 510(k) clearance for TOXOPLASMOSIS TEST KIT, manufactured by Immuno-Diagnostic Products, Inc.. The device is a Class 2 Microbiology device with product code GLZ cleared through the Traditional 510(k) pathway after a 43-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1981
Decision
43d
Days
Class 2
Risk

K811562 is an FDA 510(k) clearance for the TOXOPLASMOSIS TEST KIT. Classified as Antigens, If, Toxoplasma Gondii (product code GLZ), Class II - Special Controls.

Submitted by Immuno-Diagnostic Products, Inc. (Mchenry, US). The FDA issued a Cleared decision on July 16, 1981 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3780 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K811562

510(k) Number K811562 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 1981
Decision Date July 16, 1981
Days to Decision 43 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 102d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GLZ Device Classification - Class 2, Special Controls

Product Code GLZ Antigens, If, Toxoplasma Gondii
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - GLZ Antigens, If, Toxoplasma Gondii

All 17
Devices cleared under the same product code (GLZ) and FDA review panel - the closest regulatory comparables to K811562.
ANTI-TOXOPLASMA GONDII KIT
K842664 · Amico Lab, Inc. · Aug 1984
IMMUNOENZYME TEST SYS-DETECT-IGM ANTI
K832900 · Bionetic Laboratory Products · Nov 1983
POLYCHACO INDIRECT IMMUNOFLUORESCENCE
K830869 · Parasitic Disease Consultants · Aug 1983
TOXOPLASMA GONDII SEROLOGICAL REAGENTS
K803134 · Microbiological Research Corp. · Jan 1981
TOXO BIO-BEAD TITRATION KIT
K801720 · Litton Bionetics · Sep 1980
TOXO BIO-BEAD SCREEN KIT
K791611 · Litton Bionetics · Nov 1979